In the present study, we investigated bone geometry, microstructure, and volumetric bone mineral density (vBMD) in a cohort of patients with nonradiographic axial spondyloarthritis (nr-axSpA) in order to define the early bone changes occurring in axial spondyloarthritis (axSpA) and to define potential factors for deterioration of bone microstructure. Patients with axSpA (n = 107) and healthy control subjects (n = 50) of similar age and sex were assessed for geometric, volumetric, and microstructural parameters of bone using high-resolution peripheral quantitative computed tomography (HR-pQCT) at the radius. Additionally, demographic and disease-specific characteristics of patients with axSpA were recorded. Patients with nr-axSpA and control subjects were comparable in age, sex, and body mass index. Geometric and microstructural analysis by HR-pQCT revealed a significantly reduced cortical area (p = 0.022) and cortical thickness (p = 0.006) in patients with nr-axSpA compared with control subjects. Total

In our study, edema and contrast enhancement revealing osteitis were seen on all sequences with perfect agreement between observers; however, FS T2 WI and CE FS T1 WI planes showed the highest agreement.. It is crucial to detect active sacroiliitis and differentiate it from chronic changes. Establishing early diagnosis of active sacroiliitis and monitoring it for potential changes after therapies are of particular importance. MRI plays an important role to evaluate sacroiliitis and shows the degree of inflammation without using ionizing radiation.. The earliest signs of sacroiliitis can be identified using MRI. Periarticular bone edema is associated with increased signal in FS FSE T2 W or STIR sequences and with contrast-enhancement in FS FSE T1 W sequences after administration of gadolinium (14). We found that edema and contrast enhancement of periarticular bone revealing active sacroiliitis was shown with the highest agreement and kappa value between observers on CE FS T1 WI within all ...

Current classification criteria for axial spondyloarthritis (axSpA) provide for the inclusion of patients with a wide range of presentations and manifestations. While not considered a formal subclassification, patients are often divided into radiographic or nonradiographic axSpA based on the presence or absence of radiographic sacroiliitis. This review will focus on nonradiographic axSpA and will discuss clinical manifestations of disease that distinguish, or in many cases do not distinguish, this entity from other individuals with axSpA. This review will also cover treatment paradigms for nonradiographic axSpA, particularly the use of biologic therapies, where current data suggest that nonradiographic disease should be managed largely the same as radiographic disease, or classical ankylosing spondylitis.

We confirmed a similar burden of disease (as determined by self-reported disease activity, impaired function, and quality of life) in patients with nonradiographic axial SpA (n = 232) and those with radiographic axial SpA (n = 838). Patients with radiographic axial SpA had higher median levels of acute-phase reactants and higher median AS Disease Activity Scores (ASDAS; 3.2 versus 3.0). Anti-TNF treatment was initiated in 363 patients with radiographic axial SpA and 102 patients with nonradiographic axial SpA, preferentially in those with sacroiliitis on magnetic resonance imaging, peripheral arthritis, a higher C-reactive protein (CRP) level, a higher ASDAS, and a higher Bath Ankylosing Spondylitis Disease Activity Index level. The ASAS criteria for 40% improvement responses at 1 year were higher in patients with radiographic axial SpA compared with those with nonradiographic axial SpA (48.1% versus 29.6%; odds ratio [OR] 2.2, 95% confidence interval [95% CI] 1.12-4.46, P = 0.02). The ...

Postpartum inflammatory sacroiliitis is a well known clinical entity, treatment for which is conservative. Pyogenic sacroiliitis also has been reported in literature following caesarian section. We report a rare case of postpartum tuberculous (TB) sa

We show that low-dose IFX therapy is highly effective in reducing spinal inflammation observed on MRI. This effect was recorded in all patients who had inflammation at baseline. We also show that methods for quantifying spinal inflammation by MRI are equally and highly discriminatory, whether assessment is limited to only the most severely affected regions of the spine (6 DVU score) or includes the entire spine (23 DVU score). The data also reflect the discordance between MRI-defined and clinically defined outcome measures, which has been observed4,19.. The degree of reduction in spinal inflammation using the SPARCC method is comparable to that reported for adalimumab at 12 weeks, with reduction from baseline scores of 54% compared to an increase in the placebo group of 9% using the SPARCC 6 DVU method19. This is similar to reports assessing patients on higher doses of IFX (5 mg/kg) but using a different scoring method and assessing patients at 24 weeks20. A decrease in spinal inflammation has ...

To investigate the diagnostic values of T2 mapping and diffusion-weighted imaging (DWI) for active sacroiliitis in ankylosing spondylitis (AS) and to evalu

Sacroiliitis describes inflammation of the SI joint that can be caused by various causative mechanisms, including injury, degeneration and infection. An inflamed sacroiliac joint may also be a warning sign of autoimmune disease or even a serious mindbody disorder.

Inflammation of the SACROILIAC JOINT. It is characterized by lower back pain, especially upon walking, fever, UVEITIS; PSORIASIS; and decreased range of motion. Many factors are associated with and cause sacroiliitis including infection; injury to spine, lower back, and pelvis; DEGENERATIVE ARTHRITIS; and pregnancy ...

Readbag users suggest that 53-60 sacroiliitis.p65 is worth reading. The file contains 8 page(s) and is free to view, download or print.

ABBOTT PARK, Ill. - Patients with a form of arthritis that affects young adults taking a drug made by Abbott experienced improvements in their condition after a year of treatment, according to late-stage clinical trial results. Abbott announced Monday the first long-term patient-reported health outcomes data for the phase-3 ABILITY-1 trial of Humira (adalimumab) in patients with nonradiographic axial spondyloarthritis, or nr-axSpA. Results of the trial were presented at the American College of Rheumatologys annual scientific meeting in Washington.

Health related message boards offering discussions of numerous health topics including allergies, cancer, diabetes, heart disease, exercise, attention deficit disorder, diet, and nutrition.

en] Basal cell carcinomas (BCC) are the most common malignant neoplasms in humans. Clinical misdiagnoses are not uncommon. These cancers are classified according to their histological and clinical characteristics which exhibit distinct malignant behaviours. It is important to be aware of the different clinical presentations both for the accurate diagnosis and tumour management. We report the case of a 78-year-old man, who presented an unusual pedunculated and pigmented BCC. This combined aspect is rarely encountered ...

Patients were seen at clinic visits every 7.0% in patients with type 2 diabetes has having diabetes, who are likely to be rep- different clinical presentations were me- lin regimen consisted of a once-daily dose 23 centers.12 All were initially treated by of long-acting or isophane insulin. If the lin therapy. Since type 2 diabetes is char- acterized by steady deterioration of glu- more difficult to attain near-normal gly- insulin doses at 6 and 9 years from diag- cemic control target levels. We report the scribed, by a dietitian, a low-fat, high- 34 U, respectively. At 9 years, the median these target levels with each of the agents months on this diet, patients were strati- fied into 1 of the following therapies ac- Patients ...

The research collaboration brings together Evotecs leading induced pluripotent stem cell (iPSC) platform and broad drug discovery capabilities with Immuneerings unique artificial intelligence-driven drug discovery platform to accelerate ligand identification for novel targets.. As part of the collaboration, Evotec will use Immuneerings proprietary computational drug discovery platform Fluency to analyse public and proprietary data to advance identification of novel drug candidates that can ultimately lead to new medicines for rare hereditary metabolic diseases.. Evotec chief scientific officer Dr Cord Dohrmann said: We are very excited to collaborate with Immuneering on its unique AI-driven approach to ligand identification.. This is a significant opportunity to develop novel drugs targeting disorders of lysosomes that drive different clinical presentations in many rare genetic metabolic and neurodegenerative diseases with high unmet medical need. We look forward to exploring the powerful ...

Sacroiliitis can cause pain in your buttocks or lower back, and can extend down one or both legs. Viagra information in marathi on viagra order online canada. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. Whats people lookup in this blog: Floor Meaning In Marathi; Floor Test Meaning In Marathi The female inlet is larger and oval in shape, while the male. This content does not have an Arabic version. arthritis meaning in marathi + arthritis meaning in marathi 06 Dec 2020 Psoriatic arthritis, or PsA, affects many people with psoriasis. The outer vaginal opening is normally partly covered by a membrane called the hymen . In either foot placement, the hips should be open, with the bent knee pointing towards the side. [18]. The muscles of the thigh can be subdivided into adductors (medial group), extensors (anterior group), and flexors (posterior group). The lateral lumbosacral ligament, partly ...

Aphthoid ulcers are seen to affect the neoterminal ileum and the colonic mucosa adjacent to the ileocolic anastomosis in a patient who had had a previous extensive colonic resection for Crohns disease. A tight stricture is also apparent at the site of anastomosis (arrow), in keeping with recurrent disease. The patient also has sacroiliitis. ti, terminal ileum; c, colon ...

Results. We found 10.1% of UA (38/375) versus 7.2% (403/5584) of controls were HLA-B27-positive (OR 1.5, 95% CI 1.0-2.1; p = 0.037). HLA-B27-positive patients with UA had more SpA features than HLA-B27-negative patients (mean 1.6, SD 1.0, and 0.9 SD 0.6; p , 0.001), but patients with SpA had significantly more SpA features (mean 4.5, SD 1.5; p , 0.001). Family history and preceding infection were features more common in HLA-B27-positive than in HLA-B27-negative UA (15.8% vs 1.3%, p = 0.04 and 15.8% vs 2.6%, p = 0.04). After HLA-B27 testing, 21 additional patients (5.6%) with UA could potentially have been classified with pSpA according to the ASAS criteria. ...

Table of Content. 1. Report Introduction. 2. Axial Spondyloarthritis 3. Axial Spondyloarthritis Current Treatment Patterns. 4. Axial Spondyloarthritis - DelveInsights Analytical Perspective. 5. Therapeutic Assessment. 6. Axial Spondyloarthritis Late Stage Products (Phase-III). 7. Axial Spondyloarthritis Mid Stage Products (Phase-II). 8. Early Stage Products (Phase-I). 9. Pre-clinical Products and Discovery Stage Products. 10. Inactive Products. 11. Dormant Products. 12. Axial Spondyloarthritis Discontinued Products. 13. Axial Spondyloarthritis Product Profiles. 14. Axial Spondyloarthritis Key Companies. 15. Axial Spondyloarthritis Key Products. 16. Dormant and Discontinued Products. 17. Axial Spondyloarthritis Unmet Needs. 18. Axial Spondyloarthritis Future Perspectives. 19. Axial Spondyloarthritis Analyst Review 20. Appendix. 21. Report Methodology. *The table of contents is not exhaustive; the final content may vary. Visit to get the sample report: ...

Table of Content. 1. Report Introduction. 2. Axial Spondyloarthritis 3. Axial Spondyloarthritis Current Treatment Patterns. 4. Axial Spondyloarthritis - DelveInsights Analytical Perspective. 5. Therapeutic Assessment. 6. Axial Spondyloarthritis Late Stage Products (Phase-III). 7. Axial Spondyloarthritis Mid Stage Products (Phase-II). 8. Early Stage Products (Phase-I). 9. Pre-clinical Products and Discovery Stage Products. 10. Inactive Products. 11. Dormant Products. 12. Axial Spondyloarthritis Discontinued Products. 13. Axial Spondyloarthritis Product Profiles. 14. Axial Spondyloarthritis Key Companies. 15. Axial Spondyloarthritis Key Products. 16. Dormant and Discontinued Products. 17. Axial Spondyloarthritis Unmet Needs. 18. Axial Spondyloarthritis Future Perspectives. 19. Axial Spondyloarthritis Analyst Review 20. Appendix. 21. Report Methodology. *The table of contents is not exhaustive; the final content may vary. Visit to get the sample report: ...

TY - JOUR. T1 - Magnetic resonance imaging of septic sacroiliitis. AU - Sandrasegaran, K.. AU - Saifuddin, A.. AU - Coral, A.. AU - Butt, W. P.. PY - 1994/5/1. Y1 - 1994/5/1. N2 - Five cases of septic sacroiliitis diagnosed by magnetic resonance imaging (MRI) are presented. Imaging was performed between 2 and 14 days after onset of symptoms and consisted of varying combinations of coronal short tau inversion recovery (STIR), axial T2-weighted spin echo (SE), and coronal and axial pre- and postcontrast T1-weighted SE scans. Abnormalities included demonstration of sacroiliac joint effusions, bone oedema and adjacent inflammation as high signal on STIR and T2-weighted SE scans, and identification of abscesses in two cases as rim-enhancing lesions anterior to the joint on gadolinium-enhanced T1-weighted SE scans. The role of MRI and other forms of imaging in septic sacroiliitis is discussed.. AB - Five cases of septic sacroiliitis diagnosed by magnetic resonance imaging (MRI) are presented. Imaging ...

Results 115 patients (54.8%) fulfilled the modified New York criteria for AS in their radiographic part in the opinion of both readers at baseline, while 95 patients (45.2%) were classified as non-radiographic axial spondyloarthritis. More patients with non-radiographic spondyloarthritis (10.5%) compared with AS (4.4%) showed an estimated true progression by at least one grade according to both readers, although the difference between the two groups was statistically non-significant. The rate of progression from non-radiographic axial spondyloarthritis to AS was 11.6% over 2 years. An elevated level of C-reactive protein (CRP) at baseline was a strong positive predictor of radiographic sacroiliitis progression in non-radiographic axial spondyloarthritis and AS (OR 3.65 and 5.08, respectively, p,0.05).. ...

Results 115 patients (54.8%) fulfilled the modified New York criteria for AS in their radiographic part in the opinion of both readers at baseline, while 95 patients (45.2%) were classified as non-radiographic axial spondyloarthritis. More patients with non-radiographic spondyloarthritis (10.5%) compared with AS (4.4%) showed an estimated true progression by at least one grade according to both readers, although the difference between the two groups was statistically non-significant. The rate of progression from non-radiographic axial spondyloarthritis to AS was 11.6% over 2 years. An elevated level of C-reactive protein (CRP) at baseline was a strong positive predictor of radiographic sacroiliitis progression in non-radiographic axial spondyloarthritis and AS (OR 3.65 and 5.08, respectively, p,0.05).. ...

Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) is a different kind of inflammatory arthritis. It falls under an umbrella category of diseases called spondyloarthritis, which includes different types of arthritis with one distinguishing feature. There is almost always inflammation in the spine.. Back pain is the hallmark of Non-Radiographic Axial Spondyloarthritis, which sets it apart from any other type of inflammatory arthritis. Non-radiographic means the disease causes symptoms, but there is no visible damage on X-rays, the way there is with a related type of inflammatory arthritis called ankylosing spondylitis.. DelveInsights Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Report 2030 delivers an in-depth understanding of the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA), historical and forecasted epidemiology as well as the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United ...

TY - JOUR. T1 - Axial Spondyloarthritis in the Era of Precision Medicine. AU - van Bentum, Rianne E.. AU - van der Horst-Bruinsma, Irene E.. PY - 2020/5. Y1 - 2020/5. N2 - In axial spondyloarthritis (axSpA), the first treatment step is generally a nonsteroidal anti-inflammatory drug, and if insufficient, a biologic is added. Currently, most evidence is available of the biologic tumor necrosis factor-α inhibitors. In patients who have achieved sustained low disease activity, tumor necrosis factor-α inhibitor tapering is considered, although standardized tapering schedules are lacking. In axSpA patients with extra-articular manifestations, the effect of axSpA treatment on these extra-articular manifestations is important to determine the preferred therapy. Overall, it is recommended that treatment of axSpA be individualized based on the most prominent symptoms and presence of extra-articular and peripheral symptoms.. AB - In axial spondyloarthritis (axSpA), the first treatment step is generally ...

Sacroiliac Joint Pain, also known as sacroiliitis, is a common cause of low back and buttock pain that frequently misdiagnosed and goes overlooked.

TY - JOUR. T1 - Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. AU - Deodhar, Atulya (Atul). AU - Yu, David. PY - 2017. Y1 - 2017. N2 - Objective: To assess the impact of switching tumor necrosis factor (TNF)-alpha inhibitors on patients with axial spondyloarthritis (axSpA). Methods: PubMed literature searches were conducted using combinations of search terms including ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, switch/switching, drug survival, and TNF/tumor necrosis factor to identify published articles with data on outcomes related to switching biologic therapies in patients with axSpA. Results: Of the 134 studies screened, 21 were identified as reporting data on switching TNF inhibitors in patients carrying a diagnosis of axSpA or ankylosing spondylitis. The most common reasons for switching from the first TNF inhibitor were lack of efficacy (14-68%), loss of efficacy (13-61%), and adverse events/poor tolerability (13-57%). Switching ...

TY - JOUR. T1 - Incidence and prevalence of axial spondyloarthritis. T2 - Methodologic challenges and gaps in the literature. AU - Bohn, Rhonda. AU - Cooney, Maureen. AU - Deodhar, Atulya (Atul). AU - Curtis, Jeffrey R.. AU - Golembesky, Amanda. PY - 2018/1/1. Y1 - 2018/1/1. N2 - Objective The incidence and prevalence of axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic (nr-)axSpA, have been investigated in multiple populations, though there is a paucity of population-level data. Here, we identify population-based studies in AS and nr-axSpA, and describe the methodologic challenges in conducting these, outlining potential reasons for disparate incidence and prevalence estimates. Methods PubMed and Embase were searched for population-based studies providing incidence and prevalence rates, published in English from 1 Jan 2000-30 Jun 2015. Extracted information included incidence/prevalence rates, geographical population, study design, data source, case ...

Medicomat Buttocks Pain Tag Cloud Web Value. Popular Buttocks Pain and most respected Buttocks Pain website information and value.

Buttocks Pain: Where does Buttock Pain come from and how to treat it! I have great success in the treatment of buttock pain in my Physiotherapy Clinic.

Medicomat Buttocks Pain Tag Cloud Web Value. Popular Buttocks Pain and most respected Buttocks Pain website information and value.

Non-radiographic axial spondyloarthritis causes inflammation in the spine, which can lead to back pain. Learn what causes this type of arthritis, how its treated, and what to expect.

First randomized, controlled, Phase 3 study of an anti-TNF to enroll patients with active axial spondyloarthritis (axSpA), including patients with ankylosing sp

DRGs Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key axial spondyloarthritis&...

Learn more about axial spondyloarthritis, the burden for patients, how to identify the signs of the disease and the difference in how it affects men and women.

An expert in the management of axial spondyloarthritis explains how it differs from other rheumatologic conditions, highlights common comorbidities, and reacts to its overall burden on patients’ quality of life.

Scientific research in axial spondyloarthritis (axSpA) has grown significantly. Nevertheless, the patient perspective remains insufficiently explored. Usin

Buttock pain is a common complaint within the non-athletic and athletic population. Buttock pain can be a difficult problem to diagnose for healthcare professionals as there can be various causes all of which may not be detectable on specific diagnostic tests.

If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team ...

Learn about the diseases and conditions that may cause pain in the buttocks, and read about the medications used in the treatment of buttock pain. Pinpoint your symptoms and signs with MedicineNets Symptom Checker.

Lower back and buttocks pain often strike together, as both of these locations share postural muscles and neurological connections.

List of 38 causes for Sudden onset of triceps pain and Thigh pain and Buttock pain, alternative diagnoses, rare causes, misdiagnoses, patient stories, and much more.

Hip and buttock pain. In: Murtagh J. Murtagh J Ed. John Murtagh.eds. Murtaghs Diagnostic Strategies, 1e New York, NY: McGraw-Hill; . http://murtagh.mhmedical.com/content.aspx?bookid=1684§ionid=116081546. Accessed January 20, 2018 ...

Doctors give trusted, helpful answers on causes, diagnosis, symptoms, treatment, and more: Dr. Poelstra on recurring buttock pain: That lump may be an infection/abscess. Have it checked out by your doctor. You may need minor surgery.

Potential causes of extreme buttock pain include injuries, accident-related trauma, muscle overuse and diseases such as bone cancer of the pelvis and fibromyalgia. Other conditions that can cause...

Objectives: Current studies concentrate on the cytokine network and its role in the pathogenesis of spondyloarthritis (SpA). In this study, we analyzed whether the serum cytokine profile (interleukins: IL-10, IL-11, IL-12, IL-15, IL-17, IL-23 and IL-33) correlates with demographic data,...

PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.

GOMES, Kirla Wagner Poti et al. Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab. Rev. Bras. Reumatol. [online]. 2012, vol.52, n.3, pp.450-452. ISSN 0482-5004. http://dx.doi.org/10.1590/S0482-50042012000300014.. Leishmaniasis is an anthropozoonosis caused by species of Leishmania and can have different clinical presentations, depending on the parasite-host relationship. Tumor necrosis factor-α (TNF-α) is a cytokine essential to infection control, especially against intracellular parasites such as Leishmania. Anti-TNF-α strategies have had a marked impact on the treatment of rheumatic diseases, but the clinical use of those antagonists has been accompanied by an increased report of infections. We report the first case of cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with adalimumab and methotrexate in Brazil. We believe that, in this case, there was no association between the anti-TNF-α treatment and cutaneous leishmaniasis, ...

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary management of different clinical presentations of patients with CRPC in the VHA system.. The goal of this activity is to improve the multidisciplinary care of and education to veterans with CRPC regarding effective treatment options, including newer oral therapies in order to improve clinical outcomes. ...

MYH9-related disease. Mutations in MYH9 cause a Mendelian autosomal-dominant disorder known as MYH9-related disease (MYH9-RD).[36][37][38][39] All affected individuals present congenital hematological alterations consisting in thrombocytopenia, platelet macrocytosis, and inclusions of the MYH9 protein in the cytoplasm of granulocytes. Most patients develop one or more non-congenital manifestations, including sensorineural deafness, kidney damage, presenile cataracts, and/or elevation of liver enzymes.[39][40][41] The term MYH9-RD encompasses four syndromic pictures that were considered for many years as distinct disorders, namely May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome. After the identification of MYH9 as the gene responsible for all of these entities, it was recognized that they actually represent different clinical presentations of the same disease, now known as MYH9-RD or MYH9 disorder.[38] MYH9-RD is a rare disease: prevalence is estimated around ...

NCC is a complex disease with many different clinical presentations, depending on the number, stage and location of the cysticerci, but also on host age, immunity, parasite genetics, etc. Treatment of cysticercosis is cumbersome and needs hospitalisation of patients. In the last decade, there has been an evolution in cases from old/middle-aged people in rural areas (no travel history), to younger people (young immigrants or young European travellers) in urban centers. There are indications that disease patterns and treatment responses are different not only between these different age groups but also between the origins of the groups (traveller, immigrant, local, endemic-non endemic areas…). Up till now different diagnostic tools are being used; and different treatment regimens followed. There is an obvious need to define more harmonised case management procedures as well as to endorse an improved follow up and reporting system for NCC cases within the European Union.. Taeniosis can be easily ...

Multiple sclerosis (MS) is a relatively uncommon disease, but the effects can be devastating for patients with this disease. A cure is elusive, and the cause is still unknown. Different MS subtypes are being described, and healthcare providers should stay abreast of the different clinical presentations, effective management, and progression of the disease. This comprehensive overview will serve as a refresher and an update on the clinical management of multiple sclerosis.

Have you ever experienced pain in your lower back? If so, chances are it may be due to your sacroiliac joint, also known as the SI joint. The SI joint is in the lower back and it connects the bottom of your spine with your pelvis. It carries a lot of the pressure in your body because it supports your entire torso. This makes it susceptible to injury and pain because its acting as a shock absorber for your body.. SI joint pain can be caused by many factors, such as age, traumatic injury, pregnancy, or other conditions that can cause the SI joint to become inflamed. This causes pain that can be a dull ache or very sharp and can spread from your lower back to your thighs. SI joint pain may even affect your everyday movement. If you experience pain in the lower back, check with your doctor to see if it may be something that is affecting your sacroiliac joint.. ...

Non-radiographic axial Spondyloarthritis (nr-axSpA) is an autoimmune disease which causes arthritis in the spine and pelvis. While non-radiographic axial Spondyloarthritis is a very complicated name, it can be understood as: Non-radiographic: the inflammation will not show up on an x-ray (radiograph) but may show up on an MRI (magnetic resonance imaging) scan. Axial: it mainly affects the spine (rather than arms or legs). Spondyloarthritis: arthritis that affects the joints as well as sites where ligaments and tendons join the bone.. For more information, download the information sheet Non-radiographic axial Spondyloarthritis ...

The new ASAS criteria for axial SpA will facilitate the conduct of clinical trials and other studies in early axial SpA and will help establishing a diagnosis. Yet, they should not be misused as diagnostic criteria. The new criteria for peripheral SpA may better reflect the current view on periphera …

Male and female patients with axial spondyloarthritis experience the disease differently, researchers say. In a cross-sectional study of 466 patients from the ongoing observational Groningen Leeuwarden Axial Spondyloarthritis cohort patient reported measures of disease activity, physical function and quality of life were significantly worse for females. Writing in Rheumatology the researchers said the gender differences could […]

The SImpact Sacroiliac Joint Fixation System consists of cannulated implants offered in various lengths, and threaded congurations to accommodate variations in patient anatomy. It is intended for sacroiliac joint fusion for conditions including degenerative sacroiliitis and sacroiliac joint disruptions.. ...

PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.